Alnylam Pharmaceuticals | DEUDA

Precio De Mercado
332.61
Cambio Diario
18.21 5.79%
Mensual
-6.45%
Anual
33.04%
Q1 Expectativa
304.65




DEUDA Cambio Fecha
Acadia Pharmaceuticals USD 56.29M 1.36M 2025-06
Agios Pharmaceuticals USD 44.52M 4.24M 2025-09
Alnylam Pharmaceuticals USD 1.31B 11.39M 2025-09
Amgen USD 54.59B 1.62B 2025-09
Arrowhead Research USD 366.28M 13.25M 2025-09
BioCryst Pharmaceuticals USD 828.6M 510K 2024-12
BioMarin Pharmaceutical USD 603.87M 8.22M 2025-06
Incyte USD 40.41M 855K 2025-12
Ionis Pharmaceuticals USD 1.23B 192.99M 2025-09
Moderna USD 734M 7M 2025-09
Neurocrine Biosciences USD 428.4M 10.7M 2025-09
Novartis USD 32.02B 615M 2025-09
PTC Therapeutics USD 286.32M 306K 2025-09
Regeneron Pharmaceuticals USD 2.71B 400K 2025-09
Sangamo BioSciences USD 0 0 2022-06
Sanofi EUR 21.76B 530M 2025-09
Sarepta Therapeutics USD 1.35B 215.59M 2025-06
Takeda JPY 4.85T 208B 2025-12
Tectonic Therapeutic USD 876K 115K 2024-12
Ultragenyx Pharmaceutical USD 33.83M 2.46M 2025-09
Vertex Pharmaceuticals USD 1.83B 307.4M 2025-09
Xencor USD 67.93M 86.45M 2025-06


Alnylam Pharmaceuticals DEUDA - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Feb 2026.